Literature DB >> 30255642

An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).

.   

Abstract

INTRODUCTION: Transanal total mesorectal excision (TaTME) has rapidly emerged as a novel approach for rectal cancer surgery. Safety profiles are still emerging and more comparative data is urgently needed. This study aimed to compare indications and short-term outcomes of TaTME, open, laparoscopic, and robotic TME internationally.
METHODS: A pre-planned analysis of the European Society of Coloproctology (ESCP) 2017 audit was performed. Patients undergoing elective total mesorectal excision (TME) for malignancy between 1 January 2017 and 15 March 2017 by any operative approach were included. The primary outcome measure was anastomotic leak.
RESULTS: Of 2579 included patients, 76.2% (1966/2579) underwent TME with restorative anastomosis of which 19.9% (312/1966) had a minimally invasive approach (laparoscopic or robotic) which included a transanal component (TaTME). Overall, 9.0% (175/1951, 15 missing outcome data) of patients suffered an anastomotic leak. On univariate analysis both laparoscopic TaTME (OR 1.61, 1.02-2.48, P = 0.04) and robotic TaTME (OR 3.05, 1.10-7.34, P = 0.02) were associated with a higher risk of anastomotic leak than non-transanal laparoscopic TME. However this association was lost in the mixed-effects model controlling for patient and disease factors (OR 1.23, 0.77-1.97, P = 0.39 and OR 2.11, 0.79-5.62, P = 0.14 respectively), whilst low rectal anastomosis (OR 2.72, 1.55-4.77, P < 0.001) and male gender (OR 2.29, 1.52-3.44, P < 0.001) remained strongly associated. The overall positive circumferential margin resection rate was 4.0%, which varied between operative approaches: laparoscopic 3.2%, transanal 3.8%, open 4.7%, robotic 1%.
CONCLUSION: This contemporaneous international snapshot shows that uptake of the TaTME approach is widespread and is associated with surgically and pathologically acceptable results. Colorectal Disease
© 2018 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  zzm321990TMEzzm321990; Rectal cancer; TaTME; laparoscopic surgery; robotic surgery; transanal TME

Mesh:

Year:  2018        PMID: 30255642     DOI: 10.1111/codi.14376

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  13 in total

Review 1.  Transanal total mesorectal excision for rectal cancer: hype or new hope?

Authors:  Chien-Chih Chen; Yi-Ling Lai; Andy Yi-Ming Cheng; Chun-Ho Chu; I-Ping Huang; Shung-Haur Yang
Journal:  J Gastrointest Oncol       Date:  2019-12

Review 2.  Evidence-Based Strategies to Promote Long-Term Cardiac Implant Site Health: Review of the Literature.

Authors:  Leo Licari; Simona Viola; Claudia Carolla; Sofia Campanella; Giuseppe Salamone
Journal:  Cureus       Date:  2021-01-31

Review 3.  Current Status of the Management of Stage I Rectal Cancer.

Authors:  Craig Howard Olson
Journal:  Curr Oncol Rep       Date:  2020-04-02       Impact factor: 5.075

4.  Permanent stoma: a quality outcome in treatment of rectal cancer and its impact on length of stay.

Authors:  Riccardo Lemini; Iktej S Jabbal; Krystof Stanek; Shalmali R Borkar; Aaron C Spaulding; Scott R Kelley; Dorin T Colibaseanu
Journal:  BMC Surg       Date:  2021-03-25       Impact factor: 2.102

5.  What is the advantage of rectal amputation with an initial perineal approach for primary anorectal carcinoma?

Authors:  Kimihiko Funahashi; Mayu Goto; Tomoaki Kaneko; Mitsunori Ushigome; Satoru Kagami; Takamaru Koda; Yasuo Nagashima; Kimihiko Yoshida; Yasuyuki Miura
Journal:  BMC Surg       Date:  2020-02-03       Impact factor: 2.102

6.  Quality of Life in Patients With Rectal Resections and End-to-End Primary Anastomosis Using a Standardized Perioperative Pathway.

Authors:  Jonas Herzberg; Shahram Khadem; Valentin Begemann; Tim Strate; Human Honarpisheh; Salman Yousuf Guraya
Journal:  Front Surg       Date:  2022-01-07

7.  Intraoperative colon perfusion assessment using multispectral imaging.

Authors:  Neil T Clancy; António S Soares; Sophia Bano; Laurence B Lovat; Manish Chand; Danail Stoyanov
Journal:  Biomed Opt Express       Date:  2021-11-12       Impact factor: 3.732

8.  Meta-analysis of transanal versus laparoscopic total mesorectal excision for rectal cancer: a 'New Health Technology' assessment in South Korea.

Authors:  Sun-Ho Kwon; Yea-Il Joo; Seon Hahn Kim; Dae Ho Lee; Jeong-Heum Baek; Soon Sup Chung; Ji-Yeon Shin; Chang Soo Eun; Nam Kyu Kim
Journal:  Ann Surg Treat Res       Date:  2021-08-31       Impact factor: 1.859

Review 9.  Role of minimally invasive surgery for rectal cancer.

Authors:  Kurt A Melstrom; Andreas M Kaiser
Journal:  World J Gastroenterol       Date:  2020-08-14       Impact factor: 5.742

10.  Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic.

Authors: 
Journal:  Colorectal Dis       Date:  2020-11-15       Impact factor: 3.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.